Discovering The Potential Uses of IGHVIII-25-1 (G28348)

Target Name: IGHVIII-25-1

NCBI ID: G28348

IGHVIII-25-1

Other Name(s): IGHVIII251 | immunoglobulin heavy variable (III)-25-1 (pseudogene) | Immunoglobulin heavy variable (III)-25-1 (pseudogene) | 3-25.1P

Discovering The Potential Uses of IGHVIII-25-1

IGHVIII-25-1 (IGHVIII251) is a protein that is expressed in various tissues of the body, including the liver, lung, and heart. It is a member of the interleukin-high (ILH) family, which includes several different proteins that play important roles in the immune system.

One of the functions of IGHVIII-25-1 is to help regulate the immune response. It is involved in the development and maintenance of natural immunity, as well as in the regulation of adaptive immunity. This protein is also involved in the regulation of inflammation, which is important for both acute and chronic inflammatory responses.

IGHVIII-25-1 is a glycoprotein, which means that it consists of a protein that is covered with carbohydrates. These carbohydrates are important for the structure and function of the protein. They also make up the majority of the protein's mass.

IGHVIII-25-1 has been shown to have a number of potential drug-like properties. For example, it is highly soluble in water and is able to cross the blood-brain barrier. This means that it can be delivered directly to the cells in the brain and is not limited by the body's ability to absorb and transport it. Additionally, IGHVIII-25-1 has been shown to be able to induce an immune response in humans, which is an important property for a drug candidate.

One potential mechanism by which IGHVIII-25-1 may work as a drug is by targeting the immune cells that are involved in the regulation of the immune response. This could include T cells, which are a type of immune cell that play a key role in cell-mediated immunity.

In addition to its potential as a drug, IGHVIII-25-1 is also a potential biomarker. This is because it is a protein that is expressed in a variety of tissues and can be used as a protein biomarker for a variety of diseases. For example, it has been shown to be elevated in the blood of individuals with cancer, and it has been used as a biomarker for heart disease.

Overall, IGHVIII-25-1 is a protein that has a number of potential drug-like properties and may be a useful candidate for further research as a potential drug or biomarker. Further studies are needed to fully understand its functions and potential uses in the immune system.

Protein Name: Immunoglobulin Heavy Variable (III)-25-1 (pseudogene)

The "IGHVIII-25-1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about IGHVIII-25-1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets